• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study.非结核分枝杆菌呼吸道分离株患者的干扰素γ释放试验——一项初步研究
Pol J Microbiol. 2019;68(1):15-19. doi: 10.21307/pjm-2019-002.
2
Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey.结核分枝杆菌肺部感染患者γ干扰素释放试验:回顾性调查。
J Infect. 2016 Jun;72(6):706-712. doi: 10.1016/j.jinf.2016.03.011. Epub 2016 Mar 26.
3
[Evolution of IGRA researches].[IGRA研究的进展]
Kekkaku. 2008 Sep;83(9):641-52.
4
Increased isolation of nontuberculous mycobacteria among TB suspects in Northeastern, Tanzania: public health and diagnostic implications for control programmes.坦桑尼亚东北部结核病疑似患者中非结核分枝杆菌分离率增加:对控制项目的公共卫生及诊断意义
BMC Res Notes. 2016 Feb 17;9:109. doi: 10.1186/s13104-016-1928-3.
5
Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019.γ-干扰素释放试验在非结核分枝杆菌病诊断中的应用性能:一项 2011 至 2019 年的回顾性调查。
Front Cell Infect Microbiol. 2021 Feb 18;10:571230. doi: 10.3389/fcimb.2020.571230. eCollection 2020.
6
Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity).堪萨斯分枝杆菌所致伴有隐匿性脉络膜炎的葡萄膜炎:干扰素-γ释放试验(IGRA)检测的局限性(病例报告及关于眼部非结核分枝杆菌和IGRA交叉反应性的小型综述)
Int Ophthalmol. 2012 Oct;32(5):499-506. doi: 10.1007/s10792-012-9588-3. Epub 2012 Jun 2.
7
Assessment of Interferon-Gamma Release Assay in Patients with Non-Tuberculous Mycobacteria Pulmonary Disease.非结核分枝杆菌肺病患者的γ-干扰素释放试验评估
Clin Lab. 2019 Oct 1;65(10). doi: 10.7754/Clin.Lab.2019.181247.
8
Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.在人类免疫缺陷病毒感染率低、结核病负担中等的国家,使用两种干扰素-γ释放试验和结核菌素皮肤试验评估人类免疫缺陷病毒感染者和非感染者的潜伏性结核感染率。
J Microbiol Immunol Infect. 2016 Oct;49(5):729-736. doi: 10.1016/j.jmii.2014.08.010. Epub 2014 Nov 1.
9
The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.γ-干扰素释放试验在非结核分枝杆菌疾病中的表现:一项中国的回顾性研究。
BMC Pulm Med. 2016 Nov 25;16(1):163. doi: 10.1186/s12890-016-0320-3.
10
Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.γ干扰素释放试验在肿瘤坏死因子治疗的炎症性关节炎患者潜伏性结核感染检测中的应用。
Clin Rheumatol. 2012 May;31(5):785-94. doi: 10.1007/s10067-012-1938-z. Epub 2012 Jan 21.

引用本文的文献

1
Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with .VIDAS结核感染γ干扰素释放试验在辅助诊断结核感染个体中的初步性能。
J Clin Microbiol. 2025 Jun 11;63(6):e0164124. doi: 10.1128/jcm.01641-24. Epub 2025 May 14.
2
Prevalence of latent tuberculosis infection (LTBI) in healthcare workers in Latin America and the Caribbean: systematic review and meta-analysis.拉丁美洲和加勒比地区医护人员潜伏性结核感染(LTBI)的患病率:系统评价与荟萃分析
Infez Med. 2024 Sep 1;32(3):292-311. doi: 10.53854/liim-3203-4. eCollection 2024.
3
Insights into mycobacteriome composition in Mycobacterium bovis-infected African buffalo (Syncerus caffer) tissue samples.牛分枝杆菌感染非洲野牛(Syncerus caffer)组织样本中分枝杆菌组学组成的研究进展。
Sci Rep. 2024 Jul 30;14(1):17537. doi: 10.1038/s41598-024-68189-x.
4
Performance of Interferon-γ Release Assays in Patients with Infection.感染患者中γ-干扰素释放试验的表现
Infect Drug Resist. 2022 Dec 28;15:7727-7732. doi: 10.2147/IDR.S385570. eCollection 2022.
5
Mandibular Nodule Caused by Mycobacterium marinum with False Positive Interferon-γ Release Assay.由海分枝杆菌引起的下颌骨结节,伴有假阳性干扰素-γ释放试验。
Intern Med. 2023 Jun 15;62(12):1857-1859. doi: 10.2169/internalmedicine.0595-22. Epub 2022 Oct 26.
6
Management of Infectious Lymphadenitis in Children.儿童感染性淋巴结炎的管理
Children (Basel). 2021 Sep 27;8(10):860. doi: 10.3390/children8100860.
7
as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards.作为住院于肺病病房的 NTM 肺病患者的被低估病因。
Pol J Microbiol. 2021 Sep;70(3):315-320. doi: 10.33073/pjm-2021-028. Epub 2021 Sep 17.
8
Establishment and validation of a predictive model for nontuberculous mycobacterial infections in acid-fast bacilli smear-positive patients.建立并验证耐酸分枝杆菌涂片阳性患者中非结核分枝杆菌感染的预测模型。
Clin Respir J. 2021 Nov;15(11):1147-1157. doi: 10.1111/crj.13420. Epub 2021 Aug 8.
9
Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019.γ-干扰素释放试验在非结核分枝杆菌病诊断中的应用性能:一项 2011 至 2019 年的回顾性调查。
Front Cell Infect Microbiol. 2021 Feb 18;10:571230. doi: 10.3389/fcimb.2020.571230. eCollection 2020.

本文引用的文献

1
Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease.堪萨斯分枝杆菌肺病的临床、放射学和分子特征。
Respir Med. 2018 Jun;139:91-100. doi: 10.1016/j.rmed.2018.05.007. Epub 2018 May 9.
2
Clinical features of infection caused by non-tuberculous mycobacteria: 7 years' experience.非结核分枝杆菌感染的临床特征:7 年经验。
Infection. 2018 Jun;46(3):357-363. doi: 10.1007/s15010-018-1128-2. Epub 2018 Feb 23.
3
From Latent Tuberculosis Infection to Tuberculosis. News in Diagnostics (QuantiFERON-Plus).从潜伏性结核感染到结核病。诊断领域的新闻(QuantiFERON Plus)
Pol J Microbiol. 2017 Mar 30;66(1):5-8. doi: 10.5604/17331331.1234987.
4
Tuberculosis in Poland in 2015.2015年波兰的结核病情况
Przegl Epidemiol. 2017;71(3):391-403.
5
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).英国胸科学会非结核分枝杆菌肺病(NTM-PD)管理指南。
Thorax. 2017 Nov;72(Suppl 2):ii1-ii64. doi: 10.1136/thoraxjnl-2017-210927.
6
The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.γ-干扰素释放试验在非结核分枝杆菌疾病中的表现:一项中国的回顾性研究。
BMC Pulm Med. 2016 Nov 25;16(1):163. doi: 10.1186/s12890-016-0320-3.
7
Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey.结核分枝杆菌肺部感染患者γ干扰素释放试验:回顾性调查。
J Infect. 2016 Jun;72(6):706-712. doi: 10.1016/j.jinf.2016.03.011. Epub 2016 Mar 26.
8
Non-tuberculous mycobacterial lung disease (NT MLD ) in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension.慢性血栓栓塞性肺动脉高压和特发性肺动脉高压患者的非结核分枝杆菌肺病(NT MLD)
Pneumonol Alergol Pol. 2014;82(6):495-502. doi: 10.5603/PiAP.2014.0066.
9
Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark.丹麦的非结核分枝杆菌与干扰素γ释放试验的性能
PLoS One. 2014 Apr 4;9(4):e93986. doi: 10.1371/journal.pone.0093986. eCollection 2014.
10
Inventory study of non-tuberculous mycobacteria in the European Union.欧盟中非结核分枝杆菌的库存研究。
BMC Infect Dis. 2014 Feb 6;14:62. doi: 10.1186/1471-2334-14-62.

非结核分枝杆菌呼吸道分离株患者的干扰素γ释放试验——一项初步研究

Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study.

作者信息

Augustynowicz-Kopeć Ewa, Siemion-Szcześniak Izabela, Zabost Anna, Wyrostkiewicz Dorota, Filipczak Dorota, Oniszh Karina, Gawryluk Dariusz, Radzikowska Elżbieta, Korzybski Damian, Szturmowicz Monika

机构信息

Department of Microbiology, National Research Institute of Tuberculosis and Lung Diseases , Warsaw , Poland.

The First Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases , Warsaw , Poland.

出版信息

Pol J Microbiol. 2019;68(1):15-19. doi: 10.21307/pjm-2019-002.

DOI:10.21307/pjm-2019-002
PMID:31050249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7256814/
Abstract

Interferon gamma releasing assays (IGRAs) are extensively used in the diagnosis of latent tuberculosis infections. Comparing to tuberculin skin test (TST) they lack false positive results in the populations vaccinated with BCG, and in most non-tuberculous mycobacteria (NTM) infections. Nevertheless, , and may induce positive IGRAs due to RD1 homology with The aim of the study was to investigate the possible influence of NTM respiratory isolates on the results of IGRAs. 39 patients (23 females and 16 males) of median age 61 years, with negative medical history concerning tuberculosis, entered the study. Identification of NTM was performed using the niacin test and molecular method GenoType CM test (Hain Lifescience). QFT-Plus was performed in 17 patients, T-SPOT-Tb - in 23 patients. Chest X-rays and a high-resolution computed tomography of the chest have been reviewed by the experienced radiologist blinded to the results of IGRAs, in search of past tuberculosis signs. Positive IGRAs results were obtained in three out of 39 patients (8%): 22% of patients with isolates and 18% of patients with radiological signs on HRCT that might be suggestive of past tuberculosis. Positive IGRAs correlated with radiological signs suggestive of past tuberculosis (r = 0.32, = 0.04), and on the borderline with isolation of (r = 0.29, = 0.06). These findings may suggest that a positive IGRAs result, in our material, could depend mostly on asymptomatic past Tb infection. The cross-reactivity of isolates with IGRAs was less probable; nevertheless, it requires further investigations. Interferon gamma releasing assays (IGRAs) are extensively used in the diagnosis of latent tuberculosis infections. Comparing to tuberculin skin test (TST) they lack false positive results in the populations vaccinated with BCG, and in most non-tuberculous mycobacteria (NTM) infections. Nevertheless, , and may induce positive IGRAs due to RD1 homology with The aim of the study was to investigate the possible influence of NTM respiratory isolates on the results of IGRAs. 39 patients (23 females and 16 males) of median age 61 years, with negative medical history concerning tuberculosis, entered the study. Identification of NTM was performed using the niacin test and molecular method GenoType CM test (Hain Lifescience). QFT-Plus was performed in 17 patients, T-SPOT-Tb – in 23 patients. Chest X-rays and a high-resolution computed tomography of the chest have been reviewed by the experienced radiologist blinded to the results of IGRAs, in search of past tuberculosis signs. Positive IGRAs results were obtained in three out of 39 patients (8%): 22% of patients with isolates and 18% of patients with radiological signs on HRCT that might be suggestive of past tuberculosis. Positive IGRAs correlated with radiological signs suggestive of past tuberculosis (r = 0.32, = 0.04), and on the borderline with isolation of (r = 0.29, = 0.06). These findings may suggest that a positive IGRAs result, in our material, could depend mostly on asymptomatic past Tb infection. The cross-reactivity of isolates with IGRAs was less probable; nevertheless, it requires further investigations.

摘要

干扰素γ释放试验(IGRAs)广泛应用于潜伏性结核感染的诊断。与结核菌素皮肤试验(TST)相比,它们在接种卡介苗的人群以及大多数非结核分枝杆菌(NTM)感染中没有假阳性结果。然而,[某些特定的NTM]由于与[结核分枝杆菌的RD1区域]具有同源性,可能会诱导IGRAs出现阳性结果。本研究的目的是调查NTM呼吸道分离株对IGRAs结果可能产生的影响。39例患者(23例女性和16例男性)进入研究,年龄中位数为61岁,既往无结核病病史。使用烟酸试验和分子方法GenoType CM试验(海因生命科学公司)对NTM进行鉴定。17例患者进行了QFT-Plus检测,23例患者进行了T-SPOT-Tb检测。一位对IGRAs结果不知情的经验丰富的放射科医生对胸部X线和胸部高分辨率计算机断层扫描进行了复查,以寻找既往结核病的迹象。39例患者中有3例(8%)IGRAs结果呈阳性:分离出[特定NTM]的患者中有22%,HRCT上有可能提示既往结核病的放射学征象的患者中有18%。IGRAs阳性与提示既往结核病的放射学征象相关(r = 0.32,P = 0.04),与[特定NTM]的分离情况接近临界相关(r = 0.29,P = 0.06)。这些发现可能表明,在我们的研究材料中,IGRAs阳性结果可能主要取决于无症状的既往结核感染。[特定NTM]分离株与IGRAs的交叉反应可能性较小;然而,这需要进一步研究。干扰素γ释放试验(IGRAs)广泛应用于潜伏性结核感染的诊断。与结核菌素皮肤试验(TST)相比,它们在接种卡介苗的人群以及大多数非结核分枝杆菌(NTM)感染中没有假阳性结果。然而,[某些特定的NTM]由于与[结核分枝杆菌的RD1区域]具有同源性,可能会诱导IGRAs出现阳性结果。本研究的目的是调查NTM呼吸道分离株对IGRAs结果可能产生的影响。39例患者(23例女性和16例男性)进入研究,年龄中位数为61岁,既往无结核病病史。使用烟酸试验和分子方法GenoType CM试验(海因生命科学公司)对NTM进行鉴定。17例患者进行了QFT-Plus检测,23例患者进行了T-SPOT-Tb检测。一位对IGRAs结果不知情的经验丰富的放射科医生对胸部X线和胸部高分辨率计算机断层扫描进行了复查,以寻找既往结核病的迹象。39例患者中有3例(8%)IGRAs结果呈阳性:分离出[特定NTM]的患者中有22%,HRCT上有有可能提示既往结核病的放射学征象的患者中有18%。IGRAs阳性与提示既往结核病的放射学征象相关(r = 0.32,P = 0.04),与[特定NTM]的分离情况接近临界相关(r = 0.29,P = 0.06)。这些发现可能表明,在我们的研究材料中,IGRAs阳性结果可能主要取决于无症状的既往结核感染。[特定NTM]分离株与IGRAs的交叉反应可能性较小;然而,这需要进一步研究。